News

REUTERS The AI research lab, which launched in 2021, aims to transform the drug discovery and design process by ... Google boasted on the DeepMind website. Isomorphic Labs said it will use the ...
Isomorphic will use the windfall to fund development of its next-generation artificial intelligence drug design model, the company announced in a March 31 release. The AI biotech is also looking ...
Isomorphic Labs will utilise the funding to further power its AI drug design engine through frontier AI research and development and to scale and progress its drug candidate pipeline. Isomorphic ...
Isomorphic Labs is led by Chief Executive Officer Demis Hassabis, who has led Google LLC’s DeepMind artificial intelligence lab. The company is building what it describes as an AI drug design ...
de la Merced Reporting from London Over the last 12 months, Google’s efforts to use artificial intelligence to accelerate drug design have ... in Chemistry. Now Isomorphic Labs, the division ...
AlphaFold has “already potentially saved millions of dollars and hundreds of millions of years in research time,” Google boasted on the DeepMind website. Isomorphic Labs said it will use the ...